Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system

• Hauptverfasser: Miguel Betancourt-Cravioto (Verfasst von), Patricia Cervantes-Powell (Verfasst von), Roberto Tapia-Conyer (Verfasst von), Shaleesa Ledlie (Verfasst von), Sonja Gandhi-Banga (Verfasst von)
• Format: Buch
• Veröffentlicht: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Quadrivalent influenza vaccines (QIVs) are designed to prevent influenza disease caused by two influenza A viruses (H1N1 and H3N2) and both influenza B lineages. Risk-monitoring of QIVs to identify adverse events (AEs) is necessary as influenza vaccines are reformulated each year. We developed a new...